Sort
59,101 grants matching “hypertension”
Psychosocial Factors and Cardiovascular Disease
$2,422,873Joseph E. Schwartz · Columbia University Health Sciences · P01 · FY2010 · HL
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,422,873Oscar A. Carretero · Henry Ford Health System · P01 · FY2014 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,421,934Kodi S Ravichandran · University Of Virginia · P01 · FY2019 · HL
Inspiring Healthy Engagement and Learning for Vascular Dementia (I-HEAL)
$2,421,629Allison Mercedes Caban-Holt · Wake Forest University Health Sciences · RF1 · FY2025 · NS
Adolescent Bariatrics: Assessing Health Benefits & Risks
$2,418,814Thomas Harris Inge · Cincinnati Childrens Hosp Med Ctr · U01 · FY2010 · DK
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$2,415,605Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
A Human Stem Cell-Derived Podocyte Model for APOL1 Nephropathy
$2,415,000Opeyemi Ayodeji Olabisi · Duke University · DP2 · FY2019 · DK
Vasoactive Autacoids in Blood Pressure Regulation
$2,413,252Oscar A. Carretero · Henry Ford Health System · P01 · FY2006 · HL
The Role of Inflammation in Cardiovascular Disease
$2,413,071David G Harrison · Vanderbilt University Medical Center · P01 · FY2017 · HL
The Role of Inflammation in Cardiovascular Disease
$2,413,071David G Harrison · Vanderbilt University Medical Center · P01 · FY2020 · HL
The Role of Inflammation in Cardiovascular Disease
$2,413,071David G Harrison · Vanderbilt University Medical Center · P01 · FY2018 · HL
The Role of Inflammation in Cardiovascular Disease
$2,413,071David G Harrison · Vanderbilt University Medical Center · P01 · FY2019 · HL
Stem cell biology in cardiovascular regeneration
$2,412,459Manfred Boehm · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
WHI Sequencing Project (WHISP)
$2,411,094Rebecca D Jackson · Ohio State University · UC2 · FY2010 · HL
Vascular Contributors to Blood Brain Barrier Permeability and Regional White Matter Hyperintensity Progression in Young Asymptomatic People
$2,407,043Paul Alan Nyquist · Johns Hopkins University · RF1 · FY2022 · NS
Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research
$2,406,134Jorge Eduardo Chavarro · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2025 · HL
REACH-EpiVCID
$2,403,545Christopher David Anderson · Brigham And Women'S Hospital · RF1 · FY2024 · NS
Clinical Coordination Center for STEADY-PD3
$2,401,497Tanya Simuni Simuni · Northwestern University At Chicago · U01 · FY2017 · NS
Center for Stroke Disaparities Solution
$2,400,030Gbenga Godwin Ogedegbe · New York University School Of Medicine · U54 · FY2016 · NS
Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative
$2,399,651Sai Krupa Das · Tufts University Boston · UG1 · FY2025 · HD
Vasoactive Autacoids in Blood Pressure Regulation
$2,399,344Henry Ford Health System · P01 · FY2005 · HL
Topiramate as a Disease Altering Therapy for CSPN
$2,399,189A Gordon Smith · University Of Utah · U01 · FY2017 · NS
Hyaluronan Matrices in Vascular Pathologies
$2,398,153Vincent C. Hascall · Cleveland Clinic Lerner Com-Cwru · P01 · FY2012 · HL
Vasoactive Autacoids in Blood Pressure Regulation
$2,398,064Oscar A. Carretero · Henry Ford Health System · P01 · FY2008 · HL
Toxic Substances in the Environment
$2,397,655Martyn T Smith · University Of California Berkeley · P42 · FY2021 · ES